Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: The Japan Public Health Center

Journal of Clinical Oncology

Volumn 26, Issue 36, 2008, Pages 5923-5929

  Kurahashi, Norie ^a   Iwasaki, Motoki ^a   Inoue, Manami ^a   Sasazuki, Shizuka ^a   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; GLYCITEIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER RISK; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; FOOD INTAKE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; SOYBEAN;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; HUMANS; ISOFLAVONES; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES;

EID: 58049220432     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.8807     Document Type: Article

References (50)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 55:74-108, 2005
2. Yatani R, Kusano I, Shiraishi T, et al: Latent prostatic carcinoma: Pathological and epidemiological aspects. Jpn J Clin Oncol 19:319-326, 1989
3. Tsugane S, de Souza JM, Costa ML Jr, et al: Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil, 1969-78. Cancer Causes Control 1:189-193, 1990
4. Shimizu H, Ross RK, Bernstein L, et al: Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63:963-966, 1991
5. Kurahashi N, Iwasaki M, Sasazuki S, et al: Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 16:538-545, 2007
6. Kurahashi N, Sasazuki S, Iwasaki M, et al: Green tea consumption and prostate cancer risk in Japanese men: A prospective study. Am J Epidemiol 167:71-77, 2008
7. Kurahashi N, Inoue M, Iwasaki M, et al: Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev 17:930-937, 2008
8. Kurzer MS, Xu X: Dietary phytoestrogens. Annu Rev Nutr 17:353-381, 1997
9. Magee PJ, Rowland IR: Phyto-oestrogens, their mechanism of action: Current evidence for a role in breast and prostate cancer. Br J Nutr 91:513-531, 2004
10. Morton MS, Arisaka O, Miyake N, et al: Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 132:3168-3171, 2002
11. Adlercreutz H, Markkanen H, Watanabe S: Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342:1209-1210, 1993
12. Strom SS, Yamamura Y, Duphorne CM, et al: Phytoestrogen intake and prostate cancer: A case-control study using a new database. Nutr Cancer 33:20-25, 1999
13. Kolonel LN, Hankin JH, Whittemore AS, et al: Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 9:795-804, 2000
14. Lee MM, Gomez SL, Chang JS, et al: Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomarkers Prev 12:665-668, 2003
15. Sonoda T, Nagata Y, Mori M, et al: A case-control study of diet and prostate cancer in Japan: Possible protective effect of traditional Japanese diet. Cancer Sci 95:238-242, 2004
16. Heald CL, Ritchie MR, Bolton-Smith C, et al: Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr 98:388-396, 2007
17. Nagata Y, Sonoda T, Mori M, et al: Dietary isoflavones may protect against prostate cancer in Japanese men. J Nutr 137:1974-1979, 2007
18. Oishi K, Okada K, Yoshida O, et al: A case-control study of prostatic cancer with reference to dietary habits. Prostate 12:179-190, 1988
19. Lee MM, Wang RT, Hsing AW, et al: Case-control study of diet and prostate cancer in China. Cancer Causes Control 9:545-552, 1998
20. Jian L, Zhang DH, Lee AH, et al: Do preserved foods increase prostate cancer risk? Br J Cancer 90:1792-1795, 2004
21. Hedelin M, Klint A, Chang ET, et al: Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: The cancer prostate Sweden study (Sweden). Cancer Causes Control 17:169-180, 2006
22. Jacobsen BK, Knutsen SF, Fraser GE: Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control 9:553-557, 1998
23. Allen NE, Sauvaget C, Roddam AW, et al: A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 15:911-920, 2004
24. Nomura AM, Hankin JH, Lee J, et al: Cohort study of tofu intake and prostate cancer: No apparent association. Cancer Epidemiol Biomarkers Prev 13:2277-2279, 2004
25. Akaza H, Miyanaga N, Takashima N, et al: Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn J Clin Oncol 32:296-300, 2002
26. Akaza H, Miyanaga N, Takashima N, et al: Comparisons of percent equol producers between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 34:86-89, 2004
27. Ozasa K, Nakao M, Watanabe Y, et al: Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 95:65-71, 2004
28. Low YL, Taylor JI, Grace PB, et al: Phytoestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer risk. Nutr Cancer 56:31-39, 2006
29. Setchell KD, Brown NM, Lydeking-Olsen E: The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132:3577-3584, 2002
30. Setchell KD, Clerici C, Lephart ED, et al: S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 81:1072-1079, 2005
31. Watanabe S, Tsugane S, Sobue T, et al: Study design and organization of the JPHC study: Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases. J Epidemiol 11:S3-S7, 2001
32. Tsubono Y, Kobayashi M, Sasaki S, et al: Validity and reproducibility of a self-administered food frequency questionnaire used in the baseline survey of the JPHC Study Cohort I. J Epidemiol 13:S125-S133, 2003
33. Coward L, Kirk M, Albin N, et al: Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometry. Clin Chim Acta 247:121-142, 1996
34. Nagata C, Inaba S, Kawakami N, et al: Inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men. Nutr Cancer 36:14-18, 2000
35. Holzbeierlein JM, McIntosh J, Thrasher JB: The role of soy phytoestrogens in prostate cancer. Curr Opin Urol 15:17-22, 2005
36. Evans BA, Griffiths K, Morton MS: Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147:295-302, 1995
37. Horvath LG, Henshall SM, Lee CS, et al: Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 61:5331-5335, 2001
38. Leav I, Lau KM, Adams JY, et al: Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 159:79-92, 2001
39. Fixemer T, Remberger K, Bonkhoff H: Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 54:79-87, 2003
40. Landström M, Zhang JX, Hallmans G, et al: Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 36:151-161, 1998
41. Bylund A, Zhang JX, Bergh A, et al: Rye bran and soy protein delay growth and increase apoptos is of human LNCaP prostate adenocarcinoma in nude mice. Prostate 42:304-314, 2000
42. Canby-Hagino E, Hernandez J, Brand TC, et al: Looking back at PCPT: Looking forward to new paradigms in prostate cancer screening and prevention. Eur Urol 51:27-33, 2007
43. Watanabe S, Yamaguchi M, Sobue T, et al: Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 128:1710-1715, 1998
44. Yamamoto S, Sobue T, Sasaki S, et al: Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 131:2741-2747, 2001
45. Branham WS, Dial SL, Moland CL, et al: Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. J Nutr 132:658-664, 2002
46. Morito K, Hirose T, Kinjo J, et al: Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull 24:351-356, 2001
47. Song TT, Hendrich S, Murphy PA: Estrogenic activity of glycitein, a soy isoflavone. J Agric Food Chem 47:1607-1610, 1999
48. Clubbs EA, Bomser JA: Glycitein activates extracellular signal-regulated kinase via vascular endothelial growth factor receptor signaling in nontumorigenic (RWPE-1) prostate epithelial cells. J Nutr Biochem 18:525-532, 2007
49. Nakamura Y, Tsuji S, Tonogai Y: Determination of the levels of isoflavonoids in soybeans and soy-derived foods and estimation of isoflavonoids in the Japanese daily intake. J AOAC Int 83:635-650, 2000
50. Iwasaki M, Yamamoto S, Otani T, et al: Generalizability of relative risk estimates from a well-defined population to a general population. Eur J Epidemiol 21:253-262, 2006